The Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen has hired Jiri Lukas as its new director.
Lukas currently is head of the Centre for Genotoxic Stress Research at the Danish Cancer Society. The Center for Protein Research launched in 2007 and, with the hiring of Lukas, is now preparing to expand its research activities, CPR research director Matthias Mann said in a statement.
Combimatrix this week said it has named Richard Ding and Joseph Limber to its board of directors, and that former president and CEO Amit Kumar, as well as Rigdon Currie and John Abeles, will not stand for reelection at its next stockholders meeting.
Ding is CEO of BioTheranostics, a molecular diagnostics test developer and lab, and formerly was vice president of strategy and business development at BioMérieux. Limber is president and CEO of Prometheus Laboratories, a pharmaceutical and diagnostics company focused on personalized medicine. He also previously was president and CEO of Aclara BioSciences, now called Monogram Biosciences.
Quest Diagnostics named Timothy Ring to serve on its board of directors three months ago, and in a recent filing with the Securities and Exchange Commission the company said it has appointed him to sit on its compensation committee and its quality, safety, and compliance committee.
Ring is chairman and CEO of C. R. Bard, a developer, manufacturer, and marketer of medical technologies.